CA1265083A - Process for the preparation of aromatically substituted l-amino acids - Google Patents
Process for the preparation of aromatically substituted l-amino acidsInfo
- Publication number
- CA1265083A CA1265083A CA000493202A CA493202A CA1265083A CA 1265083 A CA1265083 A CA 1265083A CA 000493202 A CA000493202 A CA 000493202A CA 493202 A CA493202 A CA 493202A CA 1265083 A CA1265083 A CA 1265083A
- Authority
- CA
- Canada
- Prior art keywords
- ester
- acid
- extraction
- amino acid
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 21
- 230000008569 process Effects 0.000 title claims abstract description 20
- 150000008575 L-amino acids Chemical class 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims description 3
- 238000000605 extraction Methods 0.000 claims abstract description 12
- 230000006340 racemization Effects 0.000 claims abstract description 12
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 11
- 229960002376 chymotrypsin Drugs 0.000 claims abstract description 10
- 238000003776 cleavage reaction Methods 0.000 claims abstract description 10
- 230000007017 scission Effects 0.000 claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 8
- 239000003960 organic solvent Substances 0.000 claims abstract description 7
- 125000005907 alkyl ester group Chemical group 0.000 claims abstract description 5
- 239000011541 reaction mixture Substances 0.000 claims abstract description 3
- 150000002148 esters Chemical class 0.000 claims description 21
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 150000008574 D-amino acids Chemical class 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000012670 alkaline solution Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 abstract description 6
- 102000004190 Enzymes Human genes 0.000 abstract description 6
- 229940088598 enzyme Drugs 0.000 abstract description 6
- 230000020477 pH reduction Effects 0.000 abstract description 4
- 238000002955 isolation Methods 0.000 abstract 2
- 239000011260 aqueous acid Substances 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- 229960005190 phenylalanine Drugs 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000007792 addition Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- -1 hexane Chemical class 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 229960004799 tryptophan Drugs 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 235000008729 phenylalanine Nutrition 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- SWVMLNPDTIFDDY-UHFFFAOYSA-N hydron;methyl 2-amino-3-phenylpropanoate;chloride Chemical compound Cl.COC(=O)C(N)CC1=CC=CC=C1 SWVMLNPDTIFDDY-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- VSDUZFOSJDMAFZ-SECBINFHSA-N methyl (2r)-2-amino-3-phenylpropanoate Chemical compound COC(=O)[C@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-SECBINFHSA-N 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 229930182827 D-tryptophan Natural products 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical class [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229940043232 butyl acetate Drugs 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- XNFNGGQRDXFYMM-UHFFFAOYSA-N hydron;methyl 2-amino-3-(1h-indol-3-yl)propanoate;chloride Chemical compound [Cl-].C1=CC=C2C(CC([NH3+])C(=O)OC)=CNC2=C1 XNFNGGQRDXFYMM-UHFFFAOYSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- XNFNGGQRDXFYMM-PPHPATTJSA-N methyl (2s)-2-amino-3-(1h-indol-3-yl)propanoate;hydrochloride Chemical compound Cl.C1=CC=C2C(C[C@H](N)C(=O)OC)=CNC2=C1 XNFNGGQRDXFYMM-PPHPATTJSA-N 0.000 description 1
- VSDUZFOSJDMAFZ-UHFFFAOYSA-N methyl 2-amino-3-phenylpropanoate Chemical compound COC(=O)C(N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 150000002994 phenylalanines Chemical class 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- ZQFRXVDPMWSCHZ-UHFFFAOYSA-N propyl 2-amino-3-phenylpropanoate Chemical compound CCCOC(=O)C(N)CC1=CC=CC=C1 ZQFRXVDPMWSCHZ-UHFFFAOYSA-N 0.000 description 1
- VVHOGYQHQSPSDA-UHFFFAOYSA-N propyl 2-amino-3-phenylpropanoate;sulfuric acid Chemical compound OS(O)(=O)=O.CCCOC(=O)C(N)CC1=CC=CC=C1 VVHOGYQHQSPSDA-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Abstract of the disclosure Aromatically substituted L-amino acids are ob-tained particularly advantageously by enzymatic cleavage of the racemate of the lower alkyl esters using.alpha.-chymo-trypsin, extraction of the D-ester from the basified reac-tion mixture using an organic solvent, racemization, ex-traction of the D,L-ester using an aqueous acid, and re-turn, after concentration, to the process, and isolation of the L-amino acid from the alkaline residue from extrac-tion after acidification. The enzyme is advantageously immobilized on an inorganic carrier. The racemization is advantageously carried out on the extract, that is to say without isolation of the D-ester.
Description
~$~ 3
- 2 HOE 84/F 248 German Offenlegungsschrift 2,215,853(U.S. 3.813.317) discloses the CQnversion of rac~mic phenylalanines wlth one and tWD
ring substituents in~o the corresponding L amino ac;ds by first esterify;ng the racemate ~ith an alkanol hav;ng up S to 4 carbon atoms, subject;ng the racemic esters to the action of a chymotryps;n at an acid pH, isolating the L~
amino acid by precipitation and where appropriate~
extracting the ester of the D-amino acid from the filtrate and hydrolyzing it. The preferred enzyme is~-chymo-trypsin, and the preferred pH range for the enzymaticcleavage is 5 to 6u The liquid remaining after removal of the L-amino ac;d ;s basif;ed before the extraction of the ester of the D-amino acid~
It has no~ been found that aroma~ically substitu-ted L-amino acids are particularly advantageously access-ible by first basifying the mixture obtained from the enzymatic cleavage, then extracting the ester of the D-amino acid, racemizing, ~here appropriate after dryin~ of the extract, the ester9 and returning the racemate to the process. After extraction of the ester of the D-amino acid, the L-amino acid is isolated from the alkaline res;-due after acidification.
Thus the ir,vention relates to a process for the preparation of aromatically substituted L-amino acids by cleavage of the racemic lo~er alkyl esters using -chymo-trypsin in a ~eakly acidic aqueous medium, which comprises the reaction mixture being made ~eakly alkaline, the ester of the D-amino acid being extracted with an organic sol-vent, the ester bein~ racemized and returned to the pro-cess~ and the L-amino acid bein~ isolated from the aqueous alkaline extract after acidification. Preferred embodi-ments of this invention are illustra~ed in detail belo~
and are defined in the patent claims.
Particularly suitable aromatically substituted amino acids are tryptophan, and especially phenylalanine, tyrosine and 3,4~dihydroxyphenylalanine.
The esterification of the racemic amino acids can . ~ -., , be carried out in accordance ~ith the statements in German OffenLegungsschr;f~ 2,215~853 n Lo~er alkanols having up to 4 carbon atoms ~except tert.-bu~anol~ are preferred~
in p3rticular ~ethanol9 ethanol, n-propanol, isopropanol and n~butanol.
The~ -chymotrypsin is advantageously used in the immobilized form, inorgan;c carri~rs being pref~rred.
This immobilized enzyme is then brought into contact with the aqueous substrate solu~ion in a fixed or flu;di~ed bed. The reaction is preferably carried out at 20 to 45G, advantageously at 30C - 40C, and at a pH in the range 4.5 to 6.5, advantageously at a constant pH ;n the ranQe 5.0 to 600, depending on the ester used. The sub-strate concentration is not critical per se, and 5-~5% by ~eight is advan~ageous, in particular 10 to 15X by weight The aqueous solution of the L-amino acid and o~
the ester of the D-amino acid ~hich is obtained after the enzymatic cleavage is ~ade ~eakly alkaline, advantageously to a pH in the range 7.5 to 8.5, advantageously 8.0, and extracted - advantageously at 20 to 40C, in particular room temperature - using a suitable organic solvent.
The organic solvent ~hich is selected for the ex-traction is advantageously one whose miscibility ~ith uater is lo~, since then the race~izat;on can be carried out in a particularly advantageous manner ~ithout isola~
tion of the ester (the presence of water during the race-mization can give rise to side reactions, such as hydroly-sis). For this reason, a solvent ~hich forms an azeotrope ~ith water and hence allo~s easy drying of the extract is advantageous. However, i~ is also possible, even though not generally advantageous, to remove completely the sol-vent ~hich has been used for the extraction and to race-mize the ester as the solid.
Suitable solvents for the extraction are aliphatic hydrocarbons, such as hexane, and in particular aroma~ic hydrocarbons, such as toluene or xylene, ethers, in par-ticular lower dialkyl ethers~ such ~s d~ethyl ether, di~
isQpropyl ether or di-n-butyl ether9 ketones, in particu-lar louer dialkyl ketones, such as nethyl ethyl ketone or :
,. ,, . : :
~: .. : , :
~,;:: . "..........
_ 4 _ methyl isobutyl ketone9 halogena~ed hydrocarbons, ;n par-ticular chlorinated lower aliphatics~ such as methylene chloride, chloroform or ~etrachloromethaneO as ~ell as esters, in particular lo~er alkyl esters of lo~er alipha-tic carboxylic acids, such as ethyl acetate or butylacetate.
The racemization can be catalyzed in a manner kno~n per se by keto compounds and/or acids. Thus, in the case where the solvent is not a ke~one, addition of alde-hydes or ketones can considerably increase the rate ofracemization. The race~ization of opt;cally active amino acid esters in ketones, ~here appropriate uith the addi-tion of an acid, is disclosed in the published Japanese Patent Application 109 912/1979. It ;s also possible in this kno~n racemi~ation reaction ~o add a solvent, such as toluene, tetrachloromethane or methanol~ The racemiza-tion of free opt;cally active amino acids us;ng aldehydes and acids is disclosed in the publisehd European Patent Application 57,092 and in S~ Yamada et a(., J. Org. Chem.
48 (1983) 843~846. I~ is advantageous for ~hese keto com-pounds to be used in catalyt;c amounts, preferably 0.001 to 0.1 mole per mole of ester. Acetaldehyde and salicyl-aLdehyde are preferred.
The D, L mixture produced in the racemization is then extracted from the racemization mixture using slightly acidified ~ater, during ~hich the ester is con-verted in~o the salt form. This aqueous solution is ad-justed to the desired concentration, advantageously 5 to 15, in particular 10 to 150 X by ~eight, by addition of ~0 new substrate and is returned to the process~
The L-amino acid is isolated from the ~eakly alka-l;ne aqueous residue containing it by acidification. De-pending on the solubility of the acid, it can crystallize immediately or after concentration. The acid can also be isolated in a kno~n manner by extraction using suitable solvents. The purif;cation ;s carried out in a known manner.
The process according to the invention permits aromatically substituted L-amino acids to be obtained in :~
,, , :, .
~- .
; - , : , :, ~', .: . , yields exceeding 90% and in an opticaL purity exceeding 98~. The combina~ion of enzymatic cleavageO extraction of ~he D-es~er~ ;ts racemization and return resul~s in a par~icularly advantageous combina~;on of these operat;ons ~h;ch also allows a cont;nuous embodiment of the process.
The invention is illustrated in detail by the examples ~hich follo~. Unless other~ise stated, percen-tage data relate to ~eight.
~.~
mmobiLi~ation of~-chymotrypsin The enzyme can be immob;lized on aluminum silicate by the 0ethod of Hal~achs et al.O Biotechnology and Bio-engineering XIX t1977) 1667~1677. Ho~everO the following procedure is part;cularly preferred:
138 g of dry silica gel tparticle size 0.1 to 0.3 mm~ are taken up in 1 l of a 3.5X strength solution of 3-aminopropyltrietho~ysilane in acetone~ and the m;x ture is gently stirred at room temperature for 2 hours.
The acetone is then removed in a rotary evaporator, and the silica gel is dried ;n a vacuum drying oven at 100C
for 8 hours. The product contains 0.89 mmol of amino groups per gram of sil;ca gel. This aminated silica gel is t3ken up in ~OQ ml of 25X strength aqueous glutaraldehyde solution and is main~ained under vacuum tabout 130 mbar) at room temperature for 2 hoursO The carrier ;s then fil-tered off and thoroughly washed ~ith de;onized water.
138 9 of the s;lica gel thus activated are intro-duced ;nto a solu~;on of 13~8 g ofo~ochymotrypsin tsup-plied by Novo, 800 S Oral Grade) ;n 300 ml of 0.5 M phos~
phate buffer ~pH 7.5)~ and the mixture is st;rred at room temperature for 4 hours~ The catalyst ;s then fil~ered off and ~ashed w;th 1 l each of deionized water, saturated sodium chlor;de solut;on and deion;zed water. For stor-age, the immobil~zedc~chymotrypsin is taken up in 5DO ml 35 of 0.1 M phosphate buffer solution ~pH 7.$, 0.1 mmol sod;um az;de).
To determ;ne the act;vity, 1 9 of the immob;lized '~chymotrypsin is added to 50 ml of a 10X strength aqueous solut;on of D,L-phenylalan;ne methyl ester hydrochloride, .
. .
,:
and the solution ;s adjusted ~o pH 6.0, equilibrated at 30C and stirredO The pH is ma;ntained constant by addition of 0.1 N sodium hydrox;de solution us;ng an auto-matic burette. The amount of sodium hydroxide solution consun,ed is the measured variable and is directly propor-tional ~o the concen~ration of L-phenylalanine~
Activity: 338 U/g of carrier (dry) = 3~35 kg of L-phenyl-alanine/kg of carrier and h (U = international unit for enzyme activity, 1 U = 1 ~mol substrate minute conversion~
Enzymatic cleavage of racematP
100 9 of D,L-phenylalanine methyl ester hydrochlo-ride tresidual content of D,L~phenylalanine below 0.3%, HPLC detection limit) are placed in a reaction vessel ~hich can be thermostated and is equipped with an internal stirrer, pH electrode and automatic burette, and are dis solved in 1 l of deionized water. The pH of ~he solution is adjusted to 6.0 ~ith 5 N sodium hydroxide solution ~9~5 ml). The solution is equilibrated at 30C and is circulated by pumping at a flo~ rate of 5.0 l per hour through a column ~hich is packed ~ith 150 ml of the enzyme immobilized as ;n Example 1 tdiameter 5.D cm, bed height 8 cm).
~5 The pH of the solution is maintained at 6.0 during the reaction by addition of 5 N sodium hydroxide solution t37.B ml)~ After a reaction time of 25 minutes, according to HPLC analys;s the conversion achieved is 49.2X based on D,L phenylalanine methyl ester. The reaction is then stopped and the enzyme bed is ~ashed with 300 ml of de-ioni2ed ~ater~
Extraction of D-phenylalanine methyl ester and subsequent racemization The aqueous solution of D-phenylalanine methyl ester and L-phenylalanine obtained as in Example 2 is ad-justed to a pH of 8~0 by addition of 5 N sodium hydroxide solution ~36.5 ml), ~ith stirring, and~ at room tempera-ture, is ex~racted by shaking three times ~ith 300 ml each :: . .
'~.''' .: ' ' ' :' ~
, ~' "''' ~ '',,:
~im~ of methyl isobutyl ketone. According to HPLC analy-sis, after the th;rd e~trac~;on there ;s no longer any ester in the aqueous phase ~de~ection limit7 below 0~2X~.
14.D g of glacial acetic acid tOAS mole-equivalent based on D-ester) are added ~o the combined extracts, and the ~ater contained in the extract is removed by azeotropic distillation through a Vigreux column. The dry extract is heated under reflux for a further 2 hours, dur;ng ~hich the degree of racemization is measured by determination of the oDtical ro~ation of the solution using a polarime-ter. The solution is cooled to room temperature and is then extracted by shaking three times ~ith 300 ~l each ti~e of 0.05 N hydrochloric acid~ According to HPLC
analysis, 98.5% of the ester used is contained in the com-bined aqueous phase. This aqueous solution is adjus~edto 10X by addition of D,L-phenylaLanine methyl ester hydrochloride and ;s used for another enzymatic cleavage.
If n-he~ane, di-n-butyL ether, ~oluene or xylene are used as the extractant, then catalytic a~ounts of acetaldehyde, salicylaldehyde or benzaldehyde are added to increase the rate of the reaction~
In place of the glacial acetic acid, i~ is also possible to use hydrochloric acid, benzoic acid, citric acid, p-toluenesulfonic acid or formic acid. Without acids, the racemization takes place very much sLo~er and lasts more than 10 hours. Acid concentrat;ons exceeding 0.5 mole-equivalent br;ng about no further increase in the rate.
~e~
3û Working up and ;solation of L-phenylalanine The solution result;ng after the e~traction with methyl isobutyl ketone as in Example 3, ~hich contains about 3~5% of L-phenylalanine, is adjus~ed to pH 5~5 ~the isoelectric point of phenyLalanir,e~ using concen~rated hydrochloric acid, and is concentrated in a rotary evapo~
rator to a content of about 10% of L-phenylalanine~ The precipitated L-phenylalanine is induced to dissolve by heat;ng to 90C, and the solut;on is f;ltered hot. The clear solut;on ;s allowed to stand at roo~ temperature, ': ' ,:.. : , ' :'~
~5~
whereupon the L~phenylalan;ne separa~es out in large crys~
tals~ The mother liquor is s~ored a~ ~5C overnight, during ~h;ch ~hite crys~als separate out and are f;ltered off and ~ashed ~ith a lit~le cold ~ater. The crystals are dried ln a vacuum drying oven at 105C for 3 hours.
35.3 9 of L-phenylalanine~ or 92X based on 50 9 of l-phe-nylalanine nethyl ester hydrochloride used~ are obtained.
The optical purity is 98~5 to 99.5~.
Enzymatic cleavage of racemate-D,L-Phenylalanine ethyl ester In analogy to Example 2~ 150 9 of D,L phenylala-nine ethyl ester hydrogensulfate are dissolved in 1 l of deionized ~a~er. The pH of the solution is adjusted to 5.5 ~ith 5 N sodium hydroxide solution. The solut;on is equil;brated at 40C and is ~irculated through the column by pumping at a flow rate of 60 l/hourO the pH be;ng main-tained at 5.5 throughout the entire reaction by addit;on of 5 N sodium hydroxide solutionO
Further procPss;ng ls carr;ed out in accordance ~ith Examples 3 and 4~
~e~ .
Enzymatic cleavage of racemate:
D,L-Phenylalanine n-propyl ester D,L-Phenylalanine n-propyl ester hydrogensulfate a e reacted in analogy to Exa~ple 5, but the pH is adjus-ted to and naintained at 5.3. Further ~orking up is car-ried out in analogy to Examples 3 and 4~
It is also possible to use the isopropyl or n-butyl ester of D,L-phenylalanine ~ith equaL success.
L-Tryptophan In analogy to Example 2, 50 9 of D,L-tryptophan methyl ester hydrochloride are dissolved in 1 l of deion-ized ~ater, and the enzymatic clezvage is rarried out asdescribed~ The D-tryptophan ~ethyl ester is extracted as in Example 3 from the aqueous solution thus obtained and, in analogy to Example 4, the re~aining aqueous phase is adjusted to pH 5.9 ~isoelectric point of tryptophan) using :: :
; "
~2~5~13 _ 9 _ concentrated hydrochloric acid, and is concentrated ;n a rotary evaporator to a content of about 5X of L-trypto-phan. The crystals ~hich have separated out are filtered off, washed ~ith cold ~ater and dried at 105C ~or 3 hours.
19.4 ç, or 97X based on 25 ~ of L-tryptophan methyl ester hydrochloride used, are obtained. The optical purity is 98.7%.
~ . :
: , ~ , ~ , . :
ring substituents in~o the corresponding L amino ac;ds by first esterify;ng the racemate ~ith an alkanol hav;ng up S to 4 carbon atoms, subject;ng the racemic esters to the action of a chymotryps;n at an acid pH, isolating the L~
amino acid by precipitation and where appropriate~
extracting the ester of the D-amino acid from the filtrate and hydrolyzing it. The preferred enzyme is~-chymo-trypsin, and the preferred pH range for the enzymaticcleavage is 5 to 6u The liquid remaining after removal of the L-amino ac;d ;s basif;ed before the extraction of the ester of the D-amino acid~
It has no~ been found that aroma~ically substitu-ted L-amino acids are particularly advantageously access-ible by first basifying the mixture obtained from the enzymatic cleavage, then extracting the ester of the D-amino acid, racemizing, ~here appropriate after dryin~ of the extract, the ester9 and returning the racemate to the process. After extraction of the ester of the D-amino acid, the L-amino acid is isolated from the alkaline res;-due after acidification.
Thus the ir,vention relates to a process for the preparation of aromatically substituted L-amino acids by cleavage of the racemic lo~er alkyl esters using -chymo-trypsin in a ~eakly acidic aqueous medium, which comprises the reaction mixture being made ~eakly alkaline, the ester of the D-amino acid being extracted with an organic sol-vent, the ester bein~ racemized and returned to the pro-cess~ and the L-amino acid bein~ isolated from the aqueous alkaline extract after acidification. Preferred embodi-ments of this invention are illustra~ed in detail belo~
and are defined in the patent claims.
Particularly suitable aromatically substituted amino acids are tryptophan, and especially phenylalanine, tyrosine and 3,4~dihydroxyphenylalanine.
The esterification of the racemic amino acids can . ~ -., , be carried out in accordance ~ith the statements in German OffenLegungsschr;f~ 2,215~853 n Lo~er alkanols having up to 4 carbon atoms ~except tert.-bu~anol~ are preferred~
in p3rticular ~ethanol9 ethanol, n-propanol, isopropanol and n~butanol.
The~ -chymotrypsin is advantageously used in the immobilized form, inorgan;c carri~rs being pref~rred.
This immobilized enzyme is then brought into contact with the aqueous substrate solu~ion in a fixed or flu;di~ed bed. The reaction is preferably carried out at 20 to 45G, advantageously at 30C - 40C, and at a pH in the range 4.5 to 6.5, advantageously at a constant pH ;n the ranQe 5.0 to 600, depending on the ester used. The sub-strate concentration is not critical per se, and 5-~5% by ~eight is advan~ageous, in particular 10 to 15X by weight The aqueous solution of the L-amino acid and o~
the ester of the D-amino acid ~hich is obtained after the enzymatic cleavage is ~ade ~eakly alkaline, advantageously to a pH in the range 7.5 to 8.5, advantageously 8.0, and extracted - advantageously at 20 to 40C, in particular room temperature - using a suitable organic solvent.
The organic solvent ~hich is selected for the ex-traction is advantageously one whose miscibility ~ith uater is lo~, since then the race~izat;on can be carried out in a particularly advantageous manner ~ithout isola~
tion of the ester (the presence of water during the race-mization can give rise to side reactions, such as hydroly-sis). For this reason, a solvent ~hich forms an azeotrope ~ith water and hence allo~s easy drying of the extract is advantageous. However, i~ is also possible, even though not generally advantageous, to remove completely the sol-vent ~hich has been used for the extraction and to race-mize the ester as the solid.
Suitable solvents for the extraction are aliphatic hydrocarbons, such as hexane, and in particular aroma~ic hydrocarbons, such as toluene or xylene, ethers, in par-ticular lower dialkyl ethers~ such ~s d~ethyl ether, di~
isQpropyl ether or di-n-butyl ether9 ketones, in particu-lar louer dialkyl ketones, such as nethyl ethyl ketone or :
,. ,, . : :
~: .. : , :
~,;:: . "..........
_ 4 _ methyl isobutyl ketone9 halogena~ed hydrocarbons, ;n par-ticular chlorinated lower aliphatics~ such as methylene chloride, chloroform or ~etrachloromethaneO as ~ell as esters, in particular lo~er alkyl esters of lo~er alipha-tic carboxylic acids, such as ethyl acetate or butylacetate.
The racemization can be catalyzed in a manner kno~n per se by keto compounds and/or acids. Thus, in the case where the solvent is not a ke~one, addition of alde-hydes or ketones can considerably increase the rate ofracemization. The race~ization of opt;cally active amino acid esters in ketones, ~here appropriate uith the addi-tion of an acid, is disclosed in the published Japanese Patent Application 109 912/1979. It ;s also possible in this kno~n racemi~ation reaction ~o add a solvent, such as toluene, tetrachloromethane or methanol~ The racemiza-tion of free opt;cally active amino acids us;ng aldehydes and acids is disclosed in the publisehd European Patent Application 57,092 and in S~ Yamada et a(., J. Org. Chem.
48 (1983) 843~846. I~ is advantageous for ~hese keto com-pounds to be used in catalyt;c amounts, preferably 0.001 to 0.1 mole per mole of ester. Acetaldehyde and salicyl-aLdehyde are preferred.
The D, L mixture produced in the racemization is then extracted from the racemization mixture using slightly acidified ~ater, during ~hich the ester is con-verted in~o the salt form. This aqueous solution is ad-justed to the desired concentration, advantageously 5 to 15, in particular 10 to 150 X by ~eight, by addition of ~0 new substrate and is returned to the process~
The L-amino acid is isolated from the ~eakly alka-l;ne aqueous residue containing it by acidification. De-pending on the solubility of the acid, it can crystallize immediately or after concentration. The acid can also be isolated in a kno~n manner by extraction using suitable solvents. The purif;cation ;s carried out in a known manner.
The process according to the invention permits aromatically substituted L-amino acids to be obtained in :~
,, , :, .
~- .
; - , : , :, ~', .: . , yields exceeding 90% and in an opticaL purity exceeding 98~. The combina~ion of enzymatic cleavageO extraction of ~he D-es~er~ ;ts racemization and return resul~s in a par~icularly advantageous combina~;on of these operat;ons ~h;ch also allows a cont;nuous embodiment of the process.
The invention is illustrated in detail by the examples ~hich follo~. Unless other~ise stated, percen-tage data relate to ~eight.
~.~
mmobiLi~ation of~-chymotrypsin The enzyme can be immob;lized on aluminum silicate by the 0ethod of Hal~achs et al.O Biotechnology and Bio-engineering XIX t1977) 1667~1677. Ho~everO the following procedure is part;cularly preferred:
138 g of dry silica gel tparticle size 0.1 to 0.3 mm~ are taken up in 1 l of a 3.5X strength solution of 3-aminopropyltrietho~ysilane in acetone~ and the m;x ture is gently stirred at room temperature for 2 hours.
The acetone is then removed in a rotary evaporator, and the silica gel is dried ;n a vacuum drying oven at 100C
for 8 hours. The product contains 0.89 mmol of amino groups per gram of sil;ca gel. This aminated silica gel is t3ken up in ~OQ ml of 25X strength aqueous glutaraldehyde solution and is main~ained under vacuum tabout 130 mbar) at room temperature for 2 hoursO The carrier ;s then fil-tered off and thoroughly washed ~ith de;onized water.
138 9 of the s;lica gel thus activated are intro-duced ;nto a solu~;on of 13~8 g ofo~ochymotrypsin tsup-plied by Novo, 800 S Oral Grade) ;n 300 ml of 0.5 M phos~
phate buffer ~pH 7.5)~ and the mixture is st;rred at room temperature for 4 hours~ The catalyst ;s then fil~ered off and ~ashed w;th 1 l each of deionized water, saturated sodium chlor;de solut;on and deion;zed water. For stor-age, the immobil~zedc~chymotrypsin is taken up in 5DO ml 35 of 0.1 M phosphate buffer solution ~pH 7.$, 0.1 mmol sod;um az;de).
To determ;ne the act;vity, 1 9 of the immob;lized '~chymotrypsin is added to 50 ml of a 10X strength aqueous solut;on of D,L-phenylalan;ne methyl ester hydrochloride, .
. .
,:
and the solution ;s adjusted ~o pH 6.0, equilibrated at 30C and stirredO The pH is ma;ntained constant by addition of 0.1 N sodium hydrox;de solution us;ng an auto-matic burette. The amount of sodium hydroxide solution consun,ed is the measured variable and is directly propor-tional ~o the concen~ration of L-phenylalanine~
Activity: 338 U/g of carrier (dry) = 3~35 kg of L-phenyl-alanine/kg of carrier and h (U = international unit for enzyme activity, 1 U = 1 ~mol substrate minute conversion~
Enzymatic cleavage of racematP
100 9 of D,L-phenylalanine methyl ester hydrochlo-ride tresidual content of D,L~phenylalanine below 0.3%, HPLC detection limit) are placed in a reaction vessel ~hich can be thermostated and is equipped with an internal stirrer, pH electrode and automatic burette, and are dis solved in 1 l of deionized water. The pH of ~he solution is adjusted to 6.0 ~ith 5 N sodium hydroxide solution ~9~5 ml). The solution is equilibrated at 30C and is circulated by pumping at a flo~ rate of 5.0 l per hour through a column ~hich is packed ~ith 150 ml of the enzyme immobilized as ;n Example 1 tdiameter 5.D cm, bed height 8 cm).
~5 The pH of the solution is maintained at 6.0 during the reaction by addition of 5 N sodium hydroxide solution t37.B ml)~ After a reaction time of 25 minutes, according to HPLC analys;s the conversion achieved is 49.2X based on D,L phenylalanine methyl ester. The reaction is then stopped and the enzyme bed is ~ashed with 300 ml of de-ioni2ed ~ater~
Extraction of D-phenylalanine methyl ester and subsequent racemization The aqueous solution of D-phenylalanine methyl ester and L-phenylalanine obtained as in Example 2 is ad-justed to a pH of 8~0 by addition of 5 N sodium hydroxide solution ~36.5 ml), ~ith stirring, and~ at room tempera-ture, is ex~racted by shaking three times ~ith 300 ml each :: . .
'~.''' .: ' ' ' :' ~
, ~' "''' ~ '',,:
~im~ of methyl isobutyl ketone. According to HPLC analy-sis, after the th;rd e~trac~;on there ;s no longer any ester in the aqueous phase ~de~ection limit7 below 0~2X~.
14.D g of glacial acetic acid tOAS mole-equivalent based on D-ester) are added ~o the combined extracts, and the ~ater contained in the extract is removed by azeotropic distillation through a Vigreux column. The dry extract is heated under reflux for a further 2 hours, dur;ng ~hich the degree of racemization is measured by determination of the oDtical ro~ation of the solution using a polarime-ter. The solution is cooled to room temperature and is then extracted by shaking three times ~ith 300 ~l each ti~e of 0.05 N hydrochloric acid~ According to HPLC
analysis, 98.5% of the ester used is contained in the com-bined aqueous phase. This aqueous solution is adjus~edto 10X by addition of D,L-phenylaLanine methyl ester hydrochloride and ;s used for another enzymatic cleavage.
If n-he~ane, di-n-butyL ether, ~oluene or xylene are used as the extractant, then catalytic a~ounts of acetaldehyde, salicylaldehyde or benzaldehyde are added to increase the rate of the reaction~
In place of the glacial acetic acid, i~ is also possible to use hydrochloric acid, benzoic acid, citric acid, p-toluenesulfonic acid or formic acid. Without acids, the racemization takes place very much sLo~er and lasts more than 10 hours. Acid concentrat;ons exceeding 0.5 mole-equivalent br;ng about no further increase in the rate.
~e~
3û Working up and ;solation of L-phenylalanine The solution result;ng after the e~traction with methyl isobutyl ketone as in Example 3, ~hich contains about 3~5% of L-phenylalanine, is adjus~ed to pH 5~5 ~the isoelectric point of phenyLalanir,e~ using concen~rated hydrochloric acid, and is concentrated in a rotary evapo~
rator to a content of about 10% of L-phenylalanine~ The precipitated L-phenylalanine is induced to dissolve by heat;ng to 90C, and the solut;on is f;ltered hot. The clear solut;on ;s allowed to stand at roo~ temperature, ': ' ,:.. : , ' :'~
~5~
whereupon the L~phenylalan;ne separa~es out in large crys~
tals~ The mother liquor is s~ored a~ ~5C overnight, during ~h;ch ~hite crys~als separate out and are f;ltered off and ~ashed ~ith a lit~le cold ~ater. The crystals are dried ln a vacuum drying oven at 105C for 3 hours.
35.3 9 of L-phenylalanine~ or 92X based on 50 9 of l-phe-nylalanine nethyl ester hydrochloride used~ are obtained.
The optical purity is 98~5 to 99.5~.
Enzymatic cleavage of racemate-D,L-Phenylalanine ethyl ester In analogy to Example 2~ 150 9 of D,L phenylala-nine ethyl ester hydrogensulfate are dissolved in 1 l of deionized ~a~er. The pH of the solution is adjusted to 5.5 ~ith 5 N sodium hydroxide solution. The solut;on is equil;brated at 40C and is ~irculated through the column by pumping at a flow rate of 60 l/hourO the pH be;ng main-tained at 5.5 throughout the entire reaction by addit;on of 5 N sodium hydroxide solutionO
Further procPss;ng ls carr;ed out in accordance ~ith Examples 3 and 4~
~e~ .
Enzymatic cleavage of racemate:
D,L-Phenylalanine n-propyl ester D,L-Phenylalanine n-propyl ester hydrogensulfate a e reacted in analogy to Exa~ple 5, but the pH is adjus-ted to and naintained at 5.3. Further ~orking up is car-ried out in analogy to Examples 3 and 4~
It is also possible to use the isopropyl or n-butyl ester of D,L-phenylalanine ~ith equaL success.
L-Tryptophan In analogy to Example 2, 50 9 of D,L-tryptophan methyl ester hydrochloride are dissolved in 1 l of deion-ized ~ater, and the enzymatic clezvage is rarried out asdescribed~ The D-tryptophan ~ethyl ester is extracted as in Example 3 from the aqueous solution thus obtained and, in analogy to Example 4, the re~aining aqueous phase is adjusted to pH 5.9 ~isoelectric point of tryptophan) using :: :
; "
~2~5~13 _ 9 _ concentrated hydrochloric acid, and is concentrated ;n a rotary evaporator to a content of about 5X of L-trypto-phan. The crystals ~hich have separated out are filtered off, washed ~ith cold ~ater and dried at 105C ~or 3 hours.
19.4 ç, or 97X based on 25 ~ of L-tryptophan methyl ester hydrochloride used, are obtained. The optical purity is 98.7%.
~ . :
: , ~ , ~ , . :
Claims (10)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the preparation of aromatically sub-stituted L-amino acids by enzymatic cleavage of the race-mate of the lower alkyl esters using .alpha.-chymotrypsin in the weakly acid pH range and extraction of the ester of the D form, which comprises the reaction mixture obtained in the enzymatic cleavage being made weakly alkaline, the ester of the D-amino acid being extracted from this alka-line solution using an organic solvent, and being race-mized, whereupon the racemate is returned to the process, and the extracted alkaline solution is made weakly acid, whereupon the L-amino acid is isolated from it.
2. The process as claimed in claim 1, wherein the .alpha.-chymotrypsin is used in the immobilized form.
3. The process as claimed in claim 2, wherein the -chymotrypsin is immobilized on an inorganic carrier.
4. The process as claimed in claim 1, wherein an organic solvent of low miscibility with water is used for the extraction of the D-ester.
5. The process as claimed in claim 2 or claim 3, wherein an organic solvent of low miscibility with water is used for the extraction of the D-ester.
6. The process as claimed in claim 4, wherein the solvent used forms an azeotrope with water.
7. The process as claimed in claim 1, 2 or 3, wherein the extract, where appropriate dried, of the D-ester is subjected to the racemization.
8. The process as claimed in claim 1, 2 or 3, wherein the racemized ester is extracted under acid conditions and, after concentration, is returned to the process.
9. The process as claimed in claim 1, 2 or 3, wherein the ester is an alkyl ester having 1 to 4 carbon atoms, excepting tert.-butyl.
10. The process as claimed in claim 1, 2 or 3, wherein the ester is a methyl, ethyl, n-propyl, isopropyl or n-butyl ester of phenylalanine or tryptophan.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP3438189.9 | 1984-10-18 | ||
| DE19843438189 DE3438189A1 (en) | 1984-10-18 | 1984-10-18 | METHOD FOR PRODUCING AROMATICALLY SUBSTITUTED L-AMINO ACIDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1265083A true CA1265083A (en) | 1990-01-30 |
Family
ID=6248201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000493202A Expired - Fee Related CA1265083A (en) | 1984-10-18 | 1985-10-17 | Process for the preparation of aromatically substituted l-amino acids |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0178553B1 (en) |
| JP (1) | JPS61108398A (en) |
| AT (1) | ATE56472T1 (en) |
| CA (1) | CA1265083A (en) |
| CS (1) | CS258132B2 (en) |
| DE (2) | DE3438189A1 (en) |
| DK (1) | DK475585A (en) |
| ES (1) | ES8609186A1 (en) |
| FI (1) | FI854025A7 (en) |
| GR (1) | GR852491B (en) |
| HU (1) | HUT39414A (en) |
| IL (1) | IL76740A0 (en) |
| NO (1) | NO854127L (en) |
| PT (1) | PT81320B (en) |
| ZA (1) | ZA857971B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3618465A1 (en) * | 1986-06-02 | 1987-12-03 | Hoechst Ag | CARRYING OUT BIO CATALYST REACTIONS IN A FLUID BED REACTOR WITH A 2-PHASE LIQUID SYSTEM |
| DE3622662A1 (en) * | 1986-07-05 | 1988-01-14 | Hoechst Ag | METHOD FOR CONTINUOUS BIOCATALYTIC IMPLEMENTATION OF SUBSTRATES WHICH ARE SLIGHTLY SOLUBLE IN AQUEOUS SOLUTIONS |
| US5002871A (en) * | 1986-08-18 | 1991-03-26 | The Coca-Cola Company | Enzymatic membrane method for the synthesis and separation of peptides |
| DE3839379A1 (en) * | 1988-11-22 | 1990-05-23 | Hoechst Ag | METHOD FOR PRODUCING TRIPEPTIDES |
| US5025325A (en) * | 1989-10-13 | 1991-06-18 | Hewlett-Packard Company | Graphics scaling method for high resolution printers |
| DE19546532C2 (en) * | 1995-12-13 | 2000-04-20 | Degussa | Process for obtaining optically active L-alpha-aminocarboxylic acids from corresponding racemic D, L-alpha-aminocarboxylic acids |
| FR2778671B1 (en) * | 1998-05-14 | 2002-07-05 | Rhone Poulenc Agrochimie | NEW PROCESS FOR THE PREPARATION OF SYNTHESIS INTERMEDIATES |
| EP1434870B1 (en) * | 2001-09-25 | 2006-12-27 | F. Hoffmann-La Roche Ag | Enzymatic process for the preparation of substituted 2-amino-3-(2-amino-phenylsulfanyl)-propionic acid |
| JP5028672B2 (en) * | 2007-05-23 | 2012-09-19 | ボイス パテント ゲーエムベーハー | Waste paper cutting rotor |
| JP4934881B2 (en) * | 2007-05-23 | 2012-05-23 | ボイス パテント ゲーエムベーハー | Waste paper cutting rotor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA947214A (en) * | 1971-04-02 | 1974-05-14 | Antoine D'iorio | Resolution of racemates of ring-substituted phenylalanines |
| US3878043A (en) * | 1973-01-02 | 1975-04-15 | Univ Southern Illinois | Method for preparing L-dopa and novels compounds useful therein |
-
1984
- 1984-10-18 DE DE19843438189 patent/DE3438189A1/en not_active Withdrawn
-
1985
- 1985-10-04 DE DE8585112563T patent/DE3579663D1/en not_active Expired - Fee Related
- 1985-10-04 AT AT85112563T patent/ATE56472T1/en not_active IP Right Cessation
- 1985-10-04 EP EP85112563A patent/EP0178553B1/en not_active Expired - Lifetime
- 1985-10-14 HU HU853963A patent/HUT39414A/en unknown
- 1985-10-15 GR GR852491A patent/GR852491B/el unknown
- 1985-10-16 FI FI854025A patent/FI854025A7/en not_active Application Discontinuation
- 1985-10-16 CS CS857385A patent/CS258132B2/en unknown
- 1985-10-16 ES ES547901A patent/ES8609186A1/en not_active Expired
- 1985-10-17 PT PT81320A patent/PT81320B/en unknown
- 1985-10-17 ZA ZA857971A patent/ZA857971B/en unknown
- 1985-10-17 NO NO854127A patent/NO854127L/en unknown
- 1985-10-17 CA CA000493202A patent/CA1265083A/en not_active Expired - Fee Related
- 1985-10-17 JP JP60230056A patent/JPS61108398A/en active Pending
- 1985-10-17 IL IL76740A patent/IL76740A0/en unknown
- 1985-10-17 DK DK475585A patent/DK475585A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES8609186A1 (en) | 1986-09-01 |
| IL76740A0 (en) | 1986-02-28 |
| DK475585A (en) | 1986-04-19 |
| PT81320A (en) | 1985-11-01 |
| ZA857971B (en) | 1986-05-28 |
| NO854127L (en) | 1986-04-21 |
| EP0178553B1 (en) | 1990-09-12 |
| ES547901A0 (en) | 1986-09-01 |
| CS738585A2 (en) | 1987-12-17 |
| HUT39414A (en) | 1986-09-29 |
| JPS61108398A (en) | 1986-05-27 |
| EP0178553A3 (en) | 1987-04-29 |
| CS258132B2 (en) | 1988-07-15 |
| GR852491B (en) | 1986-02-11 |
| FI854025L (en) | 1986-04-19 |
| DE3438189A1 (en) | 1986-04-24 |
| FI854025A7 (en) | 1986-04-19 |
| ATE56472T1 (en) | 1990-09-15 |
| PT81320B (en) | 1987-05-18 |
| DE3579663D1 (en) | 1990-10-18 |
| FI854025A0 (en) | 1985-10-16 |
| EP0178553A2 (en) | 1986-04-23 |
| DK475585D0 (en) | 1985-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1265083A (en) | Process for the preparation of aromatically substituted l-amino acids | |
| CA1052716A (en) | Process for the enzymatic resolution of dl-phenyl glycine amide into its optically active antipodes | |
| JPH1081648A (en) | Enantiomerangereicherte malonic acid monoester alphamonosubstituted with tertiary hydrocarbon group or its salt and its production | |
| EP0459455B1 (en) | Process for producing optically active alpha-hydroxyesters | |
| US2511867A (en) | Method fob separating enantiomers | |
| JP2003201284A (en) | Method for producing substituted thiazoline and its intermediate | |
| CA1236787A (en) | Enantioselective hydrolysis of n-acylamino acid esters using a combined enzyme system | |
| JPH1180149A (en) | Optical resolution of (±) -chromancarboxylic acid | |
| Pattabiraman et al. | Comparative studies of the specificities of α-chymotrypsin and subtilisin BPN′. Studies with flexible substrates | |
| Lawson | The conformation of substrates during hydrolysis at the active site of chymotrypsin | |
| AU662134B2 (en) | Process for the enzymatic hydrolysis of a carboxylic acid derivative | |
| US4613691A (en) | Preparation of amino acids from unsaturated hydantoins | |
| CN101547893B (en) | Method for collection of L-biphenylalanine compound salt, and method for collection of biphenylalanine ester compound using the same | |
| JP3704719B2 (en) | Process for producing optically active 3-aminobutanoic acid and its ester intermediate | |
| CA2111595C (en) | Process for the enzymatic preparation of optically active transglycidic acid esters | |
| JP3160879B2 (en) | Preparation of optically active amino acid derivatives | |
| AU596158B2 (en) | Process for the separation of L-leucine and L-isoleucine | |
| US4698432A (en) | Process for the resolution of (±) 2-[2'-(p-fluorophenyl)-5'-benzoxazolyl]-propionic acid | |
| US5756812A (en) | Process for the preparation of pure (S,S)-N-(1-ethoxycarbonyl-3-phenylpropyl) alanine | |
| EP0349066A1 (en) | Preparation of enantiomers of dropropizine | |
| SU1659402A1 (en) | Method for obtaining optically active fluoro-amino acids | |
| US4731477A (en) | Process for the ring cleavage of 2-isopropyl-5,5-dimethylthiazolidines substituted in the 4-position | |
| JP2697096B2 (en) | Separation method of optically active 4-hydroxy-2-cyclopentenones | |
| JPH0632633B2 (en) | Process for producing optically active carboxylic acid | |
| CA2011782A1 (en) | Process for preparing benzylpyruvic acids and esters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |